Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance1-9 and Innovation – The New SOFIA™ Flow 88 Offers Reliable Trackability, Proximal Stability and ...

More than 25,000 Devices Implanted Worldwide from 2010-20251 ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned ...

"Terumo Neuro's SOFIA 88 Neurovascular Support Catheter is truly one of the best products in this category, especially when using a short 8F sheath," said Dr. Ameer Hassan, Head of Neuroscience ...

Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today unveiled new real-world U.S. physician preference data for the SOFIA™ 88 ...

As Terumo Neuro, the company is poised to continue its legacy of innovation with an enhanced focus on driving impactful growth and leveraging Terumo’s global resources and reputation.

NASHVILLE, Tenn., July 14, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today unveiled new real-world U.S ...

Data on file, Terumo Neuro. Pierot L, Moret J, Barreau X, et al. Safety and efficacy of aneurysm treatment with WEB in the cumulative population of three prospective, multicenter series.

The SOFIATM 88 Neurovascular Support Catheter was commercially launched in the U.S. on May 13, 2025, as the latest addition to Terumo Neuro's global stroke portfolio.

As Terumo Neuro, the company is poised to continue its legacy of innovation with an enhanced focus on driving impactful growth and leveraging Terumo’s global resources and reputation.

ALISO VIEJO, Calif. & NEW ORLEANS--(BUSINESS WIRE)--In honor of World Stroke Day on October 29, 2024, Terumo Neuro has partnered with Tulane University School of Medicine and Dr. Kendrick Johnson ...

As Terumo Neuro, the company is poised to continue its legacy of innovation with an enhanced focus on driving impactful growth and leveraging Terumo’s global resources and reputation.

ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th ...